The Business Case for Life Sciences in the Cloud
Life sciences companies are looking for cost-efficient, robust and agile products to help them handle the changing regulatory landscape. Of course, such products will require a modern IT infrastructure — one that is secure, can scale and will provide disaster recovery. This combination would allow life sciences companies to deploy solutions faster and scale their capabilities to meet business and regulatory demands.
It can be a tall order to get the necessary funds to build a strong infrastructure and focus the business on high-priority projects. In some cases, it’s not even an option. In this environment, many IT and business professionals are turning to validated cloud computing.
Cloud computing is widely used across different industries. In fact, a study from Chadwick Martin Bailey noted that 80% of IT professionals are already using cloud services. Such services are highly flexible and cost-effective, and can help companies meet their tactical and strategic goals.
There are many opportunities for life sciences companies to invest in the cloud. A good reference of a life sciences application well-suited to the cloud is related to the requirement for identification of medicinal products (IDMP). This standard will likely bring about many regulatory changes in the initial period and will mean that life sciences companies will need new solutions to apply the changes with agility and flexibility.
The cloud, and in particular an as-a-service offering, will provide the most flexible and cost-effective approach to IDMP.